Real-time enrollment status for this oculopharyngeal muscular dystrophy clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 2:06 AM UTC
| NCT Number | NCT06185673 |
| Recruiting Status | Recruiting |
| Condition | Oculopharyngeal Muscular Dystrophy |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Benitec Biopharma, Inc. |
| Last Updated on CT.gov | December 31, 2025 (Dec 31, 2025) |
As of July 20, 2026: Clinical trial NCT06185673 is currently recruiting participants. This phase1 study for oculopharyngeal muscular dystrophy is actively seeking new participants at 1 location across the United States. The study is sponsored by Benitec Biopharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06185673 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06185673 was last updated Dec 31, 2025 (December 31, 2025). HelloStudys verifies this status automatically.